NASDAQ : NUWE
Nuwellis, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.78 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.30M |
| Enterprise Value | -1.42M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 405,251 |
| Shares Outstanding | 405,251 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 6.40% |
| Float | 383,697 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.46 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.97 |
| Quick Ratio | 1.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.12 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -87.83% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -251.60% |
| Weighted Average Cost of Capital (WACC) | 196.27% |
| Revenue Per Employee | $237,184 |
| Profits Per Employee | -$297,842 |
| Employee Count | 38 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.45 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -99.41% |
| 50-Day Moving Average | 6.64 |
| 200-Day Moving Average | 238.51 |
| Relative Strength Index (RSI) | 47.84 |
| Average Volume (20 Days) | 2,083,637 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 89,357 |
| Short Previous Month | 167,440 |
| Short % of Shares Out | 22.05% |
| Short % of Float | 23.29% |
| Short Ratio (days to cover) | 0.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 9.01M |
| Gross Profit | 6.28M |
| Operating Income | -12.88M |
| Pretax Income | -11.32M |
| Net Income | -11.32M |
| EBITDA | -12.73M |
| EBIT | -12.88M |
| Earnings Per Share (EPS) | n/a |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.92M |
| Total Debt | 200,000 |
| Net Cash | 3.72M |
| Net Cash Per Share | $9.18 |
| Equity (Book Value) | -2.05M |
| Book Value Per Share | -32.20 |
| Working Capital | 3.89M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -12.46M |
| Capital Expenditures | -125,000 |
| Depreciation & Amortization | 152,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.59M |
| FCF Per Share | -$31.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 69.69% |
| Operating Margin | -142.87% |
| Pretax Margin | -125.63% |
| Profit Margin | -125.63% |
| EBITDA Margin | -141.18% |
| EBIT Margin | -142.87% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -491.70% |
| FCF Yield | -546.91% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 63.11% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -52.94 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |